Skip to main content
Clinical Trials/CTRI/2020/11/029442
CTRI/2020/11/029442
Not yet recruiting
Phase 4

Comparative Evaluation of the Peri-operative Efficacy of Immuno-nutritional and Protein Supplements as a Dietary Adjunct in Participants Undergoing Surgical Management of Oral Squamous Cell Carcinoma-A Prospective Randomized Double Blind Study.

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Oral and Maxillofacial Surgery
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Participants of both the genders in the age group of 18\-70 years.
  • 2\. Participants with Oral Squamous Cell Carcinoma who will undergo surgical resection of the tumor.
  • 3\. Participants with Oral Squamous Cell Carcinoma who will undergo surgical resection of the tumor with chemotherapy and/or Radiotherapy.
  • 4\. Participants in whom the planned surgery will be performed for duration of 4\-6 hours.
  • 5\. Participants willing for study.

Exclusion Criteria

  • 1\. Participants who have upper arm deformities.
  • 2\. Participants who are declared inoperable and are planned for palliative cancer therapies like radiotherapy and chemotherapy.
  • 3\. Participants in whom upper limb skin/flap is used for reconstruction purpose.
  • 4\. Participants who are a recurrence case of oral squamous cell carcinoma.
  • 5\. Participants who have undergone previous major surgeries under GA.
  • 6\. Participants presently suffering from a condition other than oral squamous cell carcinoma that also requires surgical intervention.
  • 7\. Participants who have a Renal Disorders and risen levels of Serum Creatinine.
  • 8\. Participants who have uncontrolled Diabetes.
  • 9\. Participants in whom the surgery will be undertaken for more than 6 hours.
  • 10\. Participants with Severe Sepsis.

Outcomes

Primary Outcomes

Not specified

Similar Trials